CorVel Executive Makes Significant Stock Sale

New insider activity at CorVel ( (CRVL) ) has taken place on May 30, 2025.

VP of Accounting Jennifer Yoss recently sold 1,050 shares of CorVel stock, amounting to a total transaction value of $116,959.

Recent Updates on CRVL stock

CorVel Corporation, a company specializing in risk management and healthcare solutions, reported a significant increase in both quarterly and annual revenues and earnings per share in its latest earnings report, showcasing strong financial performance and strategic advancements. For the quarter ending March 31, 2025, CorVel’s revenues rose by 12% to $232 million, with gross profit increasing by 34% to $58 million, and earnings per share growing by 38% to $0.51. On an annual basis, revenues reached $896 million, and earnings per share climbed to $1.83. The company ended the quarter with $171 million in cash and no debt, alongside a $9 million stock repurchase. Strategically, CorVel is investing in artificial intelligence to enhance its communication and billing platforms and has launched a new strategic platform partnership in the health market. These initiatives align with its long-term strategy of combining organic growth with external partnerships, positioning the company for continued growth in the healthcare and insurance sectors.

Spark’s Take on CRVL Stock

According to Spark, TipRanks’ AI Analyst, CRVL is a Neutral.

CorVel’s strong financial performance is the most significant factor, reflecting robust growth and efficient management. However, the high P/E ratio suggests potential overvaluation, and technical indicators point to a neutral market sentiment. The absence of recent corporate events or earnings call data means these factors do not influence the score.

To see Spark’s full report on CRVL stock, click here.

More about CorVel

YTD Price Performance: 1.44%

Average Trading Volume: 135,426

Technical Sentiment Signal: Buy

Current Market Cap: $5.67B